IGF-1 (insulin-like growth factor 1) is a naturally occurring polypeptide that functions as a signaling molecule in growth and metabolic pathways. Structurally related to insulin, it is one of the most-studied growth factors in cell biology and longevity research. It is referenced here strictly as a research and educational topic.
What IGF-1 is
IGF-1 is a single-chain polypeptide of about 70 amino acids whose name reflects structural similarity to insulin. Because it sits near the boundary of “peptide” and “protein,” it is generally described as a polypeptide growth factor — see what is a peptide for that distinction and what is an amino acid for the building blocks.
The growth-hormone / IGF-1 axis
In the research literature IGF-1 is described as a downstream mediator in the growth-hormone axis and a ligand for the IGF-1 receptor, a receptor tyrosine kinase. This places it within the receptor-signaling families covered in receptor pathways: a researcher’s primer and the science behind cellular signaling.
Why it appears so often in research
Because IGF-1 is a hub connecting growth, cellular metabolism, and aging biology, it is a frequent variable in in-vitro and animal-model experiments. The IGF-1 / insulin signaling axis is one of the most-cited systems in longevity science — an active research area, not a clinical conclusion. The broader rationale for using defined molecules to probe such pathways is in why peptides are studied in longevity research.
IGF-1 in context with other studied molecules
| Molecule | Type | Studied pathway |
|---|---|---|
| IGF-1 | ~70-aa polypeptide | GH/IGF-1 axis, RTK signaling |
| NAD+ | Coenzyme | Energy metabolism / sirtuin signaling |
| BPC-157 | 15-aa peptide | NO / growth-factor signaling |
Verification and handling
As a defined research material, IGF-1 should carry a lot-specific Certificate of Analysis with purity and identity data; handling follows standard lyophilized-material chemistry.
Common misconceptions
Being a “growth factor” describes its biological classification in research, not a use claim. Appearing in longevity research means it is a studied variable in models — not a demonstrated human outcome. Personal health questions belong with a licensed provider.
Binding proteins and signaling specificity
In the research literature, circulating IGF-1 is described as largely associated with IGF-binding proteins (IGFBPs), which modulate how much is free to engage the IGF-1 receptor. For experimental design this matters: assay systems and the “free vs bound” distinction influence how IGF-1 signaling is interpreted, conceptually similar to the bound-versus-free distinction seen with other measured analytes. IGF-1 also has structural and receptor cross-talk with the insulin system, which is why receptor selectivity is studied carefully — a theme covered in receptor pathways. These are molecular-pharmacology research considerations, not statements about effects in people.
Receptor specificity vs the insulin receptor
Because IGF-1 is structurally related to insulin, a recurring research question is selectivity: the IGF-1 receptor and the insulin receptor are distinct but related receptor tyrosine kinases, and there is documented cross-talk and the existence of hybrid receptors in the literature. For experimental design this specificity is central — assays must account for which receptor population is engaged, conceptually similar to why receptor selectivity is emphasized for other ligands in receptor pathways and cellular signaling. This is why IGF-1 is studied as a precise tool rather than a blunt one, echoing the rationale in why peptides are studied in longevity research. These are molecular-pharmacology considerations within research systems — not statements about effects in people, and not use guidance.
Practical takeaways for researchers
Three points consolidate the IGF-1 picture for experimental work. First, classification is not a use claim: “growth factor” describes IGF-1’s role in research biology, not anything about people. Second, the free-versus-bound distinction and insulin-receptor cross-talk mean assay design must specify what is actually being measured and which receptor population is engaged — the same rigor emphasized in receptor pathways. Third, treat IGF-1 as a precise probe of a well-mapped axis, verified like any defined research material via a lot-specific Certificate of Analysis. Used this way, IGF-1 is a powerful tool for studying growth and metabolic signaling in models — while remaining strictly a research and educational topic, with personal health questions belonging to a licensed provider.
Frequently Asked Questions
What does IGF-1 stand for?
IGF-1 stands for insulin-like growth factor 1, a naturally occurring polypeptide named for its structural similarity to insulin.
Is IGF-1 a peptide or a protein?
It is a small single-chain polypeptide (~70 amino acids). The peptide/protein boundary is approximate; IGF-1 is generally described as a polypeptide growth factor.
What is IGF-1's role in biology?
In published research it is described as a signaling mediator in the growth-hormone axis and a ligand for the IGF-1 receptor, participating in growth and metabolic pathways studied in model systems.
What receptor does IGF-1 act on?
The IGF-1 receptor, a receptor tyrosine kinase — one of the receptor families described in the receptor-pathways primer. This is molecular pharmacology, not a use claim.
Why is IGF-1 studied in longevity research?
The IGF-1/insulin signaling axis is one of the most-cited pathways in aging-biology research across model organisms. It is an active scientific question, not an established clinical outcome.
How does IGF-1 relate to NAD+ or peptides like BPC-157?
They are different molecule classes studied in different (sometimes intersecting) pathways — IGF-1 in the GH/IGF axis, NAD+ in energy/sirtuin biology, BPC-157 in NO/growth-factor signaling. All are research topics, not therapies.
Is IGF-1 a drug or supplement?
No. Referenced here it is a research and educational topic and any laboratory material is for in-vitro use only — not a drug, supplement, or medical product.
Related Optimization Protocols
Reviewed by the American Peptides Education Team. Educational content only — not medical advice.
For research and educational use only. Not a drug, supplement, food, or medical product. Nothing here is medical advice, a treatment claim, or a health outcome claim. Any laboratory compounds referenced are for in-vitro research only.
